Table 2.
Stabilization time and lowest value of decreased blood cell counts in each treatment group
| Factor | rHSA/IFNα2a group | PEG‐IFNα2a 180 μg group | ||||
|---|---|---|---|---|---|---|
| Maximal reduction in parameter (Week 17) | Stabilization time | Lowest value (time) | Reduction in parameter (Week 17) | Stabilization time | Lowest value (time) | |
| Neutrophil absolute value | −0.95 × 109 l−1 | Week 4 | 0.69 × 109 l−1 (Week 2) | −1.65 × 109 l−1 | Week 7 | 0.7 × 109 l−1 (Week 9) |
| WBC count | −1.49 × 109 l−1 | Week 7 | 1.38 × 109 l−1 (Week 2) | −2.57 × 109 l−1 | Week 9 | 2.15 × 109 l−1 (Week 15) |
| Platelet count | −59.25 × 109 l−1 | Week 7 | 65 × 109 l−1 (Week 2) | −69.88 × 109 l−1 | Week 9 | 77 × 109 l−1 (Week 17) |
| Haemoglobin Absolute value | −14.25 g l−1 | Week 7 or persistently decreaseda | 110 g l−1 (Week 5) | −18.5 g l−1 | Persistently decreased | 93 g l−1 (Week 11) |
a
Week 7 (rHSA/IFNα2a 600 μg and 750 μg) or persistently decreased (rHSA/IFNα2a 900 μg); WBC, white blood cell